Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

NCT04457687 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Epilepsies, Myoclonic
Drug Resistant Epilepsy

Interventions

DRUG: Lorcaserin

Sponsor

Eisai Inc.